Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
NOF Corporation, 3-3 Chidori-cho, Kawasaki-ku, Kawasaki, Kanagawa 210-0865, Japan.
J Pharm Sci. 2017 Aug;106(8):2046-2052. doi: 10.1016/j.xphs.2017.04.042. Epub 2017 Apr 27.
Hepatic stellate cells (HSCs) are responsible for hepatic fibrosis and liver cirrhosis via their ability to produce extracellular matrices such as collagens and elastin. However, a strategy for delivering cargoes to HSCs has not been established yet. We herein report on attempts to deliver small interfering RNA (siRNA) to HSCs using several types of SS-cleavable proton-activated lipid-like materials (ssPalms) that contained myristic acid (ssPalmM) or hydrophobic vitamin A (ssPalmA) and E (ssPalmE) as hydrophobic scaffolds. We initially verified that hepatic fibrosis could induce the treatment with tetrachloromethane in terms of collagen fibrils and the expression of marker genes, type I collagen α-1, transforming growth factor β, heat shock protein 47, and α-smooth muscle actin. The siRNA silencing efficiency of the 3 LNPs was then compared using fibrosis-induced mice. Of the materials tested, LNP showed the highest efficiency, with an effective (ED)50 of approximately 0.25 mg siRNA/kg. The LNP showed a significant inhibitory effect on collagen production at a dose of 3.0 mg siRNA/kg with no evidence of any severe adverse effects. In conclusion, LNP holds considerable potential for use in the treatment of HSCs-mediated diseases.
肝星状细胞 (HSCs) 通过产生细胞外基质如胶原和弹性蛋白而导致肝纤维化和肝硬化。然而,尚未建立向 HSCs 递送载药的策略。我们在此报告了使用几种包含豆蔻酸 (ssPalmM) 或疏水性维生素 A (ssPalmA) 和 E (ssPalmE) 作为疏水性支架的 SS 可切割质子激活脂质类似物 (ssPalms) 将小干扰 RNA (siRNA) 递送至 HSCs 的尝试。我们最初验证了四氯化碳处理可以诱导胶原纤维和标记基因(I 型胶原α-1、转化生长因子β、热休克蛋白 47 和α-平滑肌肌动蛋白)的表达,从而诱导肝纤维化。然后使用诱导纤维化的小鼠比较了 3 种 LNPs 的 siRNA 沉默效率。在测试的材料中,LNP 的效率最高,ED50 约为 0.25 mg/kg siRNA。LNP 在 3.0 mg/kg siRNA 剂量下对胶原产生具有显著的抑制作用,没有任何严重不良反应的证据。总之,LNP 在治疗 HSCs 介导的疾病方面具有很大的潜力。